|
 |
||
      |
|
|
» Apply for a Grant
- FAQs - Young Investigator - Independent Investigator - Distinguished Investigator - Staglin Award » Grantee List - Young Investigators - Independent Investigators - Distinguished Investigators - Staglin Awards
» Prizes
- Lieber Prize - Falcone Prize - Ruane Prize - Goldman-Rakic Prize - Freedman Award - Klerman Award » For Grantees - Young Investigator Fact Sheet - Independent Investigator Fact Sheet - Distinguished Investigator Fact Sheet - Staglin Award Fact Sheet 
|
 Project Summary  Vladimir Coric, M.D. (Young Investigator 2003) of Connecticut Mental Health Center, is evaluating the efficacy of riluzole augmentation in SRI-refractory Obsessive Compulsive Disorder (OCD). Riluzole is thought to decrease glutamatergic activity in the central nervous system by inhibiting the release of glutamic acid from nerve terminals and noncompetively blocking the effects of glutamic acid at post-synaptic receptors. Recent neuroimaging studies have implicated increased glutamatergic activity in the pathogenesis of OCD. Program Area: ANXIETY DISORDERS\Obsessive Compulsive Disorder (OCD)\Pharmacology |
Announcements
NARSAD Award Winners
 Colleen Ann McClung, Ph.D., UT Southwestern Medical Center at Dallas, 2005 & 2007 Young Investigator Latest News from NARSAD
|
